These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23553437)

  • 21. Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells.
    Janz M; Stühmer T; Vassilev LT; Bargou RC
    Leukemia; 2007 Apr; 21(4):772-9. PubMed ID: 17268519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
    Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
    Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
    Michot JM; Lazarovici J; Ghez D; Danu A; Fermé C; Bigorgne A; Ribrag V; Marabelle A; Aspeslagh S
    Eur J Cancer; 2017 Nov; 85():67-77. PubMed ID: 28892775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.
    Buglio D; Georgakis GV; Hanabuchi S; Arima K; Khaskhely NM; Liu YJ; Younes A
    Blood; 2008 Aug; 112(4):1424-33. PubMed ID: 18541724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
    Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
    Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma.
    Ritz O; Guiter C; Dorsch K; Dusanter-Fourt I; Wegener S; Jouault H; Gaulard P; Castellano F; Möller P; Leroy K
    Leukemia; 2008 Nov; 22(11):2106-10. PubMed ID: 18401415
    [No Abstract]   [Full Text] [Related]  

  • 31. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
    Perkins C; Kim CN; Fang G; Bhalla KN
    Cancer Res; 1998 Oct; 58(20):4561-6. PubMed ID: 9788601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
    Flores ML; Castilla C; Ávila R; Ruiz-Borrego M; Sáez C; Japón MA
    Breast Cancer Res Treat; 2012 Jun; 133(3):917-28. PubMed ID: 22076480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
    Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
    Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1.
    Wang MY; Chen PS; Prakash E; Hsu HC; Huang HY; Lin MT; Chang KJ; Kuo ML
    Cancer Res; 2009 Apr; 69(8):3482-91. PubMed ID: 19351859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bcl-XL small interfering RNA enhances sensitivity of Hepg2 hepatocellular carcinoma cells to 5-fluorouracil and hydroxycamptothecin.
    Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
    Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):704-10. PubMed ID: 17033717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice.
    Darcan-Nicolaisen Y; Meinicke H; Fels G; Hegend O; Haberland A; Kühl A; Loddenkemper C; Witzenrath M; Kube S; Henke W; Hamelmann E
    J Immunol; 2009 Jun; 182(12):7501-8. PubMed ID: 19494273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells.
    Han H; Xue-Franzén Y; Miao X; Nagy E; Li N; Xu D; Sjöberg J; Björkholm M; Claesson HE
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):122-30. PubMed ID: 26115646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.